CL, R., J, Y., MA, T., DC, S., H, J., L, S., . . . J, P. (2025). An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. Frontiers in neuroscience, 19, 1516746. https://doi.org/10.3389/fnins.2025.1516746
Chicago Style (17th ed.) CitationCL, Reading, et al. "An Exploratory Analysis of Bezisterim Treatment Associated with Decreased Biological Age Acceleration, and Improved Clinical Measure and Biomarker Changes in Mild-to-moderate Probable Alzheimer's Disease." Frontiers in Neuroscience 19 (2025): 1516746. https://doi.org/10.3389/fnins.2025.1516746.
MLA (9th ed.) CitationCL, Reading, et al. "An Exploratory Analysis of Bezisterim Treatment Associated with Decreased Biological Age Acceleration, and Improved Clinical Measure and Biomarker Changes in Mild-to-moderate Probable Alzheimer's Disease." Frontiers in Neuroscience, vol. 19, 2025, p. 1516746, https://doi.org/10.3389/fnins.2025.1516746.
